Belgium· BE-AMP-SAM503626-00
Epiduo Forte 0.3 % - 2.5 %
A adapalen, kombinationen product containing adapalene, registered in Belgium by Galderma Benelux. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Adapalen, kombinationen is registered in 12 of 19 countries.
Countries holding a registration under ATC D10AD53 (adapalen, kombinationen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Adapalen, kombinationen · ATC D10AD53
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Adapalene
- Manufacturer
- Galderma Benelux
- Country
- Belgium (BE)
- ATC code
- D10AD53
- ATC class
- Adapalen, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb3541828
- be_apb3541794
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Adapalen, kombinationen in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesACNE TREATMENTJiangxi Zhongteng Pharmaceutical Co., Ltd
- United KingdomAdapalene 0.1% creamPhoenix Healthcare Distribution Ltd
- PolandAcnelecBausch Health Ireland Ltd.
- IrelandDifferin 0.1% w/w creamIMED Healthcare Ltd.,
- FranceADAPALENE TEVA 0,1 POUR CENT, crèmeTEVA SANTE
- FinlandDifferinGalderma Nordic AB
- CanadaDIFFERINGALDERMA CANADA INC
- CzechiaBELAKNEBelupo, s.r.o., Bratislava
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Differin
- Cyprus · Adaferin
- Czechia · Belakne, Differine
- Germany · Differin, Dipalen
- Denmark · Redap
- Estonia · Differin
- Spain · Differine
- Finland · Differin
- France · Adapalene Teva, Adapalene Zentiva
- United Kingdom (Northern Ireland) · Differin
- Greece · Adaferin
- Croatia · Sona
- Hungary · Differin
- Ireland · Differin
- Iceland · Differin
- Italy · Differin
- Lithuania · Differin
- Luxembourg · Differin
- Latvia · Differin
- Malta · Differin
- Netherlands · Differin
- Norway · Differin
- Poland · Acnelec, Differin
- Portugal · Differin
- Sweden · Differin
- Slovenia · Belakne
- Slovakia · Belakne, Differine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db20e6af-d9c7-490d-bc3f-45a6503d24bb GET /v1/drugs/db20e6af-d9c7-490d-bc3f-45a6503d24bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Gel",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Epiduo Forte 0.3 % - 2.5 %",
"name_fr": "Epiduo Forte 0.3 % - 2.5 %",
"name_nl": "Epiduo Forte 0.3 % - 2.5 %",
"amp_code": "SAM503626-00",
"strengths": [
"0.0030",
"0.0250",
"1.0000",
"0.5000",
"40.0000",
"40.0000"
],
"pack_count": 6,
"substances": [
"Adapalene",
"Benzoyl Peroxide Hydrous",
"Disodium Edetate",
"Docusate Sodium",
"Glycerol",
"Propylene Glycol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Adapalene, Combinations",
"authorisation_numbers": [
"BE503626",
"BE503635"
]
}See everything about adapalen, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.